Roche - 1 Year Service & Support agreement

This notice is a Notice of Intent. The Government intends to negotiate on a sole source basis with Roche Diagnostics Corp. for the procurement of a 1 year maintenance service agreement, period of performance 04/01/2015 - 03/31/2016 in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are not being requested and a written solicitation will not be issued. Submit offers on NOI-RML-C-15013

This acquisition is a Notice of Intent (NOI). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 05-80 March 2, 2015.

The North American Industry Classification System (NAICS) code for this procurement is 811219 with a small business size standard of 19.2. This requirement is not set aside for small business. CAGE Code: 51169.

The National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories, Research Technology Section (RTS) Genomics Unit requires the renewal service & support contract for the Next Generation Sequencer, GS FX CE230V. This acquisition is to continue a maintenance agreement on the Roche Sequencer to keep this equipment working optimally for all of the DIR's needs. Coverage includes: 1 Year Service & support agreement, unlimited emergency on site response within 72 hours, technical support, 1 preventative maintenance per year, and necessary warranted parts. Only qualified and certified technicians are allowed to maintenance the Sequencer and must use original manufactured parts.

Service & Support agreement
ROCHE GS FX Sequencer
Serial # 6090528
Contract Period 04/01/2015 -03/31/2016

FOB Point shall be Destination; Hamilton, MT 59840.

Place of Performance:
Rocky Mountain Laboratory
Hamilton, MT
United States

Award will be based on the capability of the item offered to meet the above stated salient characteristics, price, past performance, delivery, warranty, and the best value to the government.

The following FAR provisions apply to this acquisition:
52.212-1 Instructions to Offerors Commercial Items (April 2014)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (May 2014)
Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items
The following contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (May 2014)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (March 2015)

The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

Quoter must include the following provision in their quote and check the appropriate response.
52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Dec 2014)
(a) Definitions. "Inverted domestic corporation" and "subsidiary" have the meaning given in the clause of this contract entitled Prohibition on Contracting with Inverted Domestic Corporations (52.209-10).
(b) Government agencies are not permitted to use appropriated (or otherwise made available) funds for contracts with either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation, unless the exception at 9.108-2(b) applies or the requirement is waived in accordance with the procedures at 9.108-4.
(c) Representation. By submission of its offer, the offeror represents that- (check one)
____(1) It is not an inverted domestic corporation: and
____(2) It is not a subsidiary of an inverted domestic corporation

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html or, upon request, either by telephone or fax.

This is a firm fixed price contract in accordance with the statutory authority for this sole source requirement 41 U.S.C. 253 c as implemented by FAR 6.302-1 Only one source available , no substitutions possible and this item contains proprietary data/ patent information. THIS ANNOUCEMNENT CONSTITUTES THE ONLY SOLICITATION: QUOTATIONS ARE NOT BEING REQUESTED, AND WRITTEN SOLICITATION WILL NOT BE ISSUED. Notice of Intent for Roche Diagnostics as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes must include a statement regarding the terms and conditions herein as follows:
"The Terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition."
OR
"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"
(Quoter shall list exception(s) and rationale for the exception(s).)

Submission shall be received not later than March 24/2015 9:00 a.m. MST.

Offers may be mailed, e-mailed or faxed to Diana Rohlman ; (Fax - 406-363-9288), (diana.rohlman@nih.gov). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Diana Rohlman, (diana.rohlman@nih.gov)